Symposiums

Coronary artery disease remains the leading cause of death worldwide. There has been tremendous progress in the management of Acute Coronary Syndrome…

Summary of Presentations given at OM Pharma Lunch Symposium at the XX FIGO World Congress in Gynecology and Obstetrics, Rome, 9th October 2012

The therapeutic landscape for hormone receptor-positive (HR+) advanced breast cancer (BC) is moving from generalized endocrine therapies…

Patients with cancer often have a compromised immune system, which places them at an increased risk of infection that can extend beyond…

Mutations in HER2, also known as ERBB2, represent a distinct molecular subset of NSCLC, occurring in approximately 2–4% of cases, and are…

EpNECs are considered rare and are often associated with a poor prognosis, with up to 85% of patients presenting with advanced…

Psoriasis is a common, chronic, inflammatory skin disease characterized by accelerated epidermal proliferation. The most common subtype is…

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania and Cambier…